» Articles » PMID: 21805617

Transcatheter Closure of Large Patent Ductus Arteriosus at High Altitude with a Novel Nitinol Device

Overview
Date 2011 Aug 2
PMID 21805617
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Patent ducti arteriosi (PDAs) are more frequent and larger at high altitude than at sea level. A novel PDA closure device, the Nitocclud PDA-R, is designed specifically for both large and medium size PDAs. The initial clinical experience with a new nitinol-based device in high altitude patients with large PDAs is described.

Methods: The Nitocclud PDA-R is a self-expandable, self-centering, repositionable occluder made of one nitinol wire without use of welding. It contains several polyester membranes, is delivered with a central guide wire and is released by retraction of the central wire into the delivery catheter. The efficacy of this device was evaluated at several high altitude centers.

Results: Fifty-one patients without other congenital cardiac defects underwent transcatheter closure of PDA. Complete occlusion of the PDA was achieved in 98% of the patients. Nearly 49% of the patients had no shunt immediately after device implantation. Echocardiography revealed a complete closure rate by Doppler interrogation of 69% after 24 hr, 96% after 6 months, and 98% after 1 year. In two cases, device embolization was observed after release, and in both cases the device was easily retrieved with standard interventional techniques. There have been no episodes of delayed device migration, endocarditis, hemolysis, wire fracture, device disruption, or death.

Conclusions: The Nitocclud PDA-R device is safe and effective and can easily close very large PDAs. This device has a high rate of complete occlusion within 1 year and is easily retrieved if embolized.

Citing Articles

Initial experience using NIT-OCCLUD PDA-R device for percutaneous patent ductus arteriosus closure in Panama.

Campos-Quintero A, Lalire A, Morales L, Sinistterra S, Fernandez N Arch Cardiol Mex. 2024; 94(1):104-106.

PMID: 38507334 PMC: 11160530. DOI: 10.24875/ACM.22000228.


Pulmonary hypertension: From an orphan disease to a global epidemic.

Butrous G Glob Cardiol Sci Pract. 2020; 2020(1):e202005.

PMID: 33150150 PMC: 7590934. DOI: 10.21542/gcsp.2020.5.


Familial clustering of congenital deafness, patent ductus arteriosus, Eisenmenger complex, and differential cyanosis: A case report.

Lin T, Tseng C, Huang C, Wang K, Liang K Medicine (Baltimore). 2017; 96(24):e7105.

PMID: 28614229 PMC: 5478314. DOI: 10.1097/MD.0000000000007105.


Percutaneous closure of patent arterial ducts in patients from high altitude: a sub-Saharan experience.

Tefera E, Qureshi S, Bermudez-Canete R, Rubio L Ann Pediatr Cardiol. 2015; 8(3):196-201.

PMID: 26556965 PMC: 4608196. DOI: 10.4103/0974-2069.164690.


Transcatheter closure of a large patent ductus arteriosus with severe pulmonary arterial hypertension in a child.

Karakurt C, Elkiran O, Celik S, Kocak G Herz. 2013; 38(6):685-8.

PMID: 23861127 DOI: 10.1007/s00059-012-3738-2.